人工智能自动定量前列腺癌PET/CT骨骼肿瘤负荷:PET指数
本研究基于三个中心共168例前列腺癌患者,训练卷积神经网络(CNN)自动计算[18F]氟化物PET/CT骨骼肿瘤负荷,并在26例中评估。AI模型的PET指数与医师PET指数呈中等强度相关(平均r=0.69),优于阈值法的平均r=0.49;AI病灶检测敏感度为65-76%,医师为68-91%,阈值法为44-51%。
要点
- AI模型可全自动计算全身骨骼肿瘤负荷(PET指数),与医师评估呈中等强度相关(平均r=0.69)。
- AI模型病灶检测敏感度为65-76%,优于SUV 15阈值法的44-51%。
- 未出现所有医师均一致认为AI模型未能检测到的病灶病例。
核心结论
- 研究成功开发了基于人工智能的模型,可自动评估PET/CT骨骼肿瘤负荷,其性能优于阈值法,并提供全自动全身骨骼肿瘤负荷计算。
研究设计与样本
- 研究纳入来自三个中心的168例前列腺癌患者,分为训练组、验证组和测试组。
- 使用[18F]氟化物PET/CT扫描中骨骼病灶的人工标注训练卷积神经网络(CNN)。
- AI模型在26例患者中评估,并与医师分割及SUV 15阈值法比较。
主要发现
- AI模型PET指数与医师PET指数呈中等强度相关(平均r=0.69)。
- 阈值法PET指数与医师PET指数呈一般相关(平均r=0.49)。
- 病灶检测敏感度:AI为65-76%,医师为68-91%,阈值法为44-51%,取决于以哪位医师为参考。
- 未出现所有读者均一致认为AI模型未能检测到的病灶病例。
关键数值与推荐
- PET指数代表病灶占据的骨骼体积百分比。
- AI模型与医师PET指数的平均相关系数r=0.69。
- 阈值法PET指数与医师PET指数的平均相关系数r=0.49。
- AI病灶检测敏感度65-76%,医师68-91%,阈值法44-51%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Consistent assessment of bone metastases is crucial for patient management and clinical trials in prostate cancer (PCa). We aimed to develop a fully automated convolutional neural network (CNN)-based model for calculating PET/CT skeletal tumor burden in patients with PCa. METHODS: A total of 168 patients from three centers were divided into training, validation, and test groups. Manual annotations of skeletal lesions in [18F]fluoride PET/CT scans were used to train a CNN. The AI model was evaluated in 26 patients and compared to segmentations by physicians and to a SUV 15 threshold. PET index representing the percentage of skeletal volume taken up by lesions was estimated. RESULTS: There was no case in which all readers agreed on prevalence of lesions that the AI model failed to detect. PET index by the AI model correlated moderately strong to physician PET index (mean r = 0.69). Threshold PET index correlated fairly with physician PET index (mean r = 0.49). The sensitivity for lesion detection was 65-76% for AI, 68-91% for physicians, and 44-51% for threshold depending on which physician was considered reference. CONCLUSION: It was possible to develop an AI-based model for automated assessment of PET/CT skeletal tumor burden. The model's performance was superior to using a threshold and provides fully automated calculation of whole-body skeletal tumor burden. It could be further developed to apply to different radiotracers. Objective scan evaluation is a first step toward developing a PET/CT imaging biomarker for PCa skeletal metastases.
引用
- Lindgren Belal S, Larsson M, Holm J, et al. Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index. Eur J Nucl Med Mol Imaging. 2023. PMID: 36650356. doi:10.1007/s00259-023-06108-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。